No Data
No Data
Why Elixir Energy, Neuren, Reece, and TechnologyOne Shares Are Tumbling Today
Neuren Pharmaceuticals Gears Up for Phase 3 Trial of Genetic Disorder Drug Candidate; Shares Up 3%
Neuren Pharmaceuticals Limited (NURPF) Receives a Buy From Canaccord Genuity
Analysts Think These ASX 200 Shares Are Strong Buys
4 ASX Healthcare Stocks Having a Cracking Run on Friday
Those Who Invested in Neuren Pharmaceuticals (ASX:NEU) Three Years Ago Are up 576%
No Data
No Data